Valuation of Efficacy and Safety of Vitamin D3 Use in 80 Women Diagnosed With Fibromyalgia. Using FIQ Score and VAS.
Status:
Completed
Trial end date:
2017-12-31
Target enrollment:
Participant gender:
Summary
Fibromyalgia is a disease that significantly decreases the quality of life of people who
suffer from it, has great repercussions at the socio-economic level due to the incapacity it
produces. It is characterized by generalized pain, fatigue, sleep disorders, psychological
stress and mental alterations, besides presenting painful points in different parts of the
body to physical examination. Having few effective treatments is necessary to explore new
options in their management to improve the general conditions of the patient. Previous
studies have shown that patients with fibromyalgia have had low levels of vitamin D in the
blood, a favorable response from post-vitamin D supplementation has been seen. This vitamin
has been associated with pain pathways and with increased The perception of the same when it
is in smaller amount. We will select patients with Fibromyalgia diagnosis from the external
consultation of Rheumatology of the University Hospital "Dr. José Eleuterio González "of the
UANL, over 18 years old who have not been previously supplemented with vitamin D, will
initially be measured in blood of vitamin D, in addition to calcium as a safety measure, we
will have a group that will only receive placebo and Another that will be supplemented with
50 thousand units weekly for 12 weeks, we will apply a questionnaire that measures pain scale
and another one that measures the impact of the disease in the daily life of the patient,
this will be done in a beginning and at the end of the 12 weeks .